Published Date: 10 Mar 2023
The combination of static and dynamic computer-assisted dental implant surgery can improve the accuracy of dental implant surgery training...
Read Full NewsIrreversible nerve damage to the lower limbs is a common side effect of chemotherapy, yet up to 50% of patients are missing out on vital foot care that could significantly ease their symptoms, according to new research from ...
A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—the class of drugs behind Ozempic, Wegovy and Mounjaro, for example—may do more than regulate ...
Lung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patients live longer.
1.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
2.
Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.
3.
Screening tests that are non-invasive show promise in detecting colorectal cancer.
4.
Vaccine shows promise for pancreatic cancer, study finds
5.
For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.
1.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
2.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
3.
Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes
4.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
5.
A Closer Look at the Effects of Sickle Cell on Eyesight
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
Navigating the Complexities of Ph Negative ALL - Part XIII
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation